Digital Health in Neurology – Thematic Research
- Pages: 75
- Published: March 2021
- Report Code: GDHCHT258
Digital technologies are constantly evolving and finding new applications in healthcare. These tools can be used to track health, deliver therapeutic interventions, and contribute to research.
For many patients living with neurological conditions, treatment can be episodic and infrequent, leaving them vulnerable.
Digital health technologies provide opportunities to improve disease treatment and management for these patients, as well as being individualized to each person.
The wider digital health industry faces many challenges, particularly as tools struggle to gain reliable evidence of efficacy, hindering widespread adoption. However, the COVID-19 pandemic has accelerated innovation in digital health as patients and physicians look for alternatives to in-person care.
GlobalData forecasts that collaborations and investment will continue to drive this trend to support innovation and bring new solutions to market.
Furthermore, digital health tools will become increasingly focused on specific indications, such as neurology, where numerous healthtech companies are vying for market share. Additionally, pharma companies with therapy expertise will become more involved with digital health providers.
The report includes:
Technologies covered: digital therapeutics, mHealth, wearables, digital biomarkers, telemedicine, and virtual and augmented reality.
Indications included: mental/behaviour health conditions, such as anxiety, depression, ADHD, PTSD, and addiction, as well as chronic neurological diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy.
A review of different trends impacting the digital health landscape in neurology, including healthcare, technology, regulatory, and macroeconomic.
A value chain looking at each technology with examples of leading players and challengers.
Industry analysis with deals analysis, including pharma partnerships and an analysis of funding deals by broad therapy area.
A Pharma scorecard – the top 20 pharma companies operating in the CNS drug space (by 2020 GlobalData sales revenue) have been scored on their strength in each of the technologies using Deals, Clinical Trials, and Digital Marketing Intelligence (for apps).
Case studies looking across the different technologies.
Healthcare industry poll data, with opinions on which digital technologies are best suited for different neurology indications.
Digital Pharma Influencer analysis across neurology.
Reasons to buy
Get an overview of what digital technologies are being used to treat and monitor patients and drive research in the neurology space.
See which technologies are most suitable to different neurological conditions.
Understand what healthtech companies are active in the space, with examples of leaders and challengers by technology, and what opportunities exist for partnerships to drive innovation and provide additional value to patient offerings
Understand the competitive landscape with a review of pharma activity, including strategic partnerships and funding deals. See which companies are strong or weak in each technology with the Pharma scorecard.
Understand industry perspectives on the value of digital health tools in neurology.
Table of Contents
Pharma Companies: Assessment of Digital Health Activity in Neurology
Healthcare Industry Polls
Social Media Influencers
About the Authors
Our Thematic Research Methodology
List of Tables
Table 1: Healthcare Trends in the Neurology Digital Health Space
Table 2: Technology Trends in the Neurology Digital Health Space
Table 3: Macroeconomic Trends in the Neurology Digital Health Space
Table 4: Regulatory Trends in the Neurology Digital Health Space
Table 5: Examples of Digital Therapeutics in the Neurology Space
Table 6: Examples of mHealth Applications Across the Neurology Space
Table 7: Examples of Wearable Devices in the Neurology Space
Table 8: Examples of Digital Biomarker Software in Neurology
Table 9: Examples of VR/AR Applications in the Neurology Space
Table 10: M&As in the Neurology Digital Health Space, 2018-2021
Table 11: Examples of Strategic Partnerships in the Digital Health Neurology Space
Table 12: Examples of Strategic Partnerships in the Digital Health Neurology Space with Pharmaceutical Companies
Table 13: Examples of Funding Deals in the Digital Health Neurology Space
Table 14: Examples of Funding Deals Involving Pharmaceutical Companies
Table 15: Examples of Top Pharma Apps in the MS Space
Table 16: Examples of Public Companies in the Neurology Digital Health Space
List of Figures
Figure 1: Who Are the Leading Players in the Neurology Digital Health Space?
Figure 2: Digital Health in Neurology Value Chain
Figure 3: Examples of Digital Therapeutics Players in Neurology
Figure 4: Digital Therapeutic Downloads Increased After the Reimbursement Pathway Was Announced in Germany
Figure 5: Examples of mHealth Players in Neurology
Figure 6: Examples of Wearable Technology Players in Neurology
Figure 7: Examples of Digital Biomarkers Players in Neurology
Figure 8: Types of On-Demand Urgent Care Telemedicine Providers
Figure 9: Examples of On-Demand Telemedicine Players in Neurology
Figure 10: Examples of VR/AR Players in Neurology
Figure 11: Number of Pharma Partnerships in Neurology Digital Health, 2018–2020
Figure 12: Pharma Partnerships in Digital Health Neurology by Technology Type, 2008–2020
Figure 13: Funding Deals in Digital Health Neurology by Technology Type, 2008–2020
Figure 14: Funding Deals in Neurology Digital Health by Therapy Area, 2018–2020
Figure 15: Assessment of Pharma Activity in the Neurology Digital Health Space
Figure 16: Pear Therapeutics’ reSET/reSET-O DTx Products
Figure 17: App Downloads for Calm and Headspace, 2019–2020
Figure 18: Theranica’s Nerivio Wearable and Mobile App (left); Relivion’s Neurolief Device (right)
Figure 19: InteraXon’s Muse by InteraXon App and Device
Figure 20: Web Traffic to Mental Health-Focused Telemedicine Platforms July 2019–January 2021
Figure 21: Roche Has Posted the Highest Number of Jobs Related to Digital Biomarkers Since 2019
Figure 22: Roche’s Floodlight App Contains Tests That Measure Brain Function, Hand Function, and Mobility
Figure 23: Biogen’s Aby App
Figure 24: Industry Perspective on Therapy Areas Most Suitable for Use of Digital Health Tools
Figure 25: Industry Perspective on the Technologies Most Suitable for Mental and Behavioral Health Conditions
Figure 26: Industry Perspective on the Technologies Most Suitable for Neurological Conditions
Figure 27: Industry Perspective on the Main Benefits of Digital Health Tools
Figure 28: Industry Perspective on the Main Barriers to the Adoption of Digital Health Tools
Figure 29: Top Influencer Trends Related to Neurology Digital Health, March 2019–March 2021
Figure 30: Top Posts Related to Neurology Digital Health, 2019–2021